BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32966646)

  • 1. Phylogenetic analysis of SARS-CoV-2 in the first few months since its emergence.
    Pereson MJ; Mojsiejczuk L; Martínez AP; Flichman DM; Garcia GH; Di Lello FA
    J Med Virol; 2021 Mar; 93(3):1722-1731. PubMed ID: 32966646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Gapless, Unambiguous RNA Metagenome-Assembled Genome Sequence of a Unique SARS-CoV-2 Variant Encoding Spike S813I and ORF1a A859V Substitutions.
    Soliman MS; AbdelFattah M; Aman SMN; Ibrahim LM; Aziz RK
    OMICS; 2021 Feb; 25(2):123-128. PubMed ID: 33253058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2.
    Li X; Zai J; Zhao Q; Nie Q; Li Y; Foley BT; Chaillon A
    J Med Virol; 2020 Jun; 92(6):602-611. PubMed ID: 32104911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolutionary Tracking of SARS-CoV-2 Genetic Variants Highlights an Intricate Balance of Stabilizing and Destabilizing Mutations.
    Jacob JJ; Vasudevan K; Pragasam AK; Gunasekaran K; Veeraraghavan B; Mutreja A
    mBio; 2021 Aug; 12(4):e0118821. PubMed ID: 34281387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolutionary analysis of SARS-CoV-2 spike protein for its different clades.
    Pereson MJ; Flichman DM; Martínez AP; Baré P; Garcia GH; Di Lello FA
    J Med Virol; 2021 May; 93(5):3000-3006. PubMed ID: 33512021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular evolution and phylogenetic analysis of SARS-CoV-2 and hosts ACE2 protein suggest Malayan pangolin as intermediary host.
    Lopes LR; de Mattos Cardillo G; Paiva PB
    Braz J Microbiol; 2020 Dec; 51(4):1593-1599. PubMed ID: 32592038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolutionary and structural analysis of SARS-CoV-2 specific evasion of host immunity.
    Hussain I; Pervaiz N; Khan A; Saleem S; Shireen H; Wei DQ; Labrie V; Bao Y; Abbasi AA
    Genes Immun; 2020 Dec; 21(6-8):409-419. PubMed ID: 33273723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Virus Titer via Enhanced Furin-Mediated Spike Cleavage.
    Cheng YW; Chao TL; Li CL; Wang SH; Kao HC; Tsai YM; Wang HY; Hsieh CL; Lin YY; Chen PJ; Chang SY; Yeh SH
    mBio; 2021 Aug; 12(4):e0058721. PubMed ID: 34311586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The novel coronavirus SARS-CoV-2: From a zoonotic infection to coronavirus disease 2019.
    Dos Santos Bezerra R; Valença IN; de Cassia Ruy P; Ximenez JPB; da Silva Junior WA; Covas DT; Kashima S; Slavov SN
    J Med Virol; 2020 Nov; 92(11):2607-2615. PubMed ID: 32470173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a High-Frequency Intrahost SARS-CoV-2 Spike Variant with Enhanced Cytopathic and Fusogenic Effects.
    Rocheleau L; Laroche G; Fu K; Stewart CM; Mohamud AO; Côté M; Giguère PM; Langlois MA; Pelchat M
    mBio; 2021 Jun; 12(3):e0078821. PubMed ID: 34182784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The extent of molecular variation in novel SARS-CoV-2 after the six-month global spread.
    Bui NN; Lin YT; Huang SH; Lin CW
    Infect Genet Evol; 2021 Jul; 91():104800. PubMed ID: 33677109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular evolutionary characteristics of SARS-CoV-2 emerging in the United States.
    Wang S; Xu X; Wei C; Li S; Zhao J; Zheng Y; Liu X; Zeng X; Yuan W; Peng S
    J Med Virol; 2022 Jan; 94(1):310-317. PubMed ID: 34506640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence and expansion of highly infectious spike protein D614G mutant SARS-CoV-2 in central India.
    Sharma S; Dash PK; Sharma SK; Srivastava A; Kumar JS; Karothia BS; Chelvam KT; Singh S; Gupta A; Yadav RG; Yadav R; Greeshma TS; Kushwaha PK; Kumar RB; Nagar DP; Nandan M; Kumar S; Thavaselvam D; Dubey DK
    Sci Rep; 2021 Sep; 11(1):18126. PubMed ID: 34518554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ongoing global and regional adaptive evolution of SARS-CoV-2.
    Rochman ND; Wolf YI; Faure G; Mutz P; Zhang F; Koonin EV
    Proc Natl Acad Sci U S A; 2021 Jul; 118(29):. PubMed ID: 34292871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploration of hosts and transmission traits for SARS-CoV-2 based on the k-mer natural vector.
    Zhang Y; Wen J; Li X; Li G
    Infect Genet Evol; 2021 Sep; 93():104933. PubMed ID: 34023511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolutionary and Phenotypic Characterization of Two Spike Mutations in European Lineage 20E of SARS-CoV-2.
    Ruiz-Rodriguez P; Francés-Gómez C; Chiner-Oms Á; López MG; Jiménez-Serrano S; Cancino-Muñoz I; Ruiz-Hueso P; Torres-Puente M; Bracho MA; D'Auria G; Martinez-Priego L; Guerreiro M; Montero-Alonso M; Gómez MD; Piñana JL; ; González-Candelas F; Comas I; Marina A; Geller R; Coscolla M
    mBio; 2021 Dec; 12(6):e0231521. PubMed ID: 34781748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species.
    Moustaqil M; Ollivier E; Chiu HP; Van Tol S; Rudolffi-Soto P; Stevens C; Bhumkar A; Hunter DJB; Freiberg AN; Jacques D; Lee B; Sierecki E; Gambin Y
    Emerg Microbes Infect; 2021 Dec; 10(1):178-195. PubMed ID: 33372854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Founder Effect Led Early SARS-CoV-2 Transmission in Spain.
    Díez-Fuertes F; Iglesias-Caballero M; García-Pérez J; Monzón S; Jiménez P; Varona S; Cuesta I; Zaballos Á; Jiménez M; Checa L; Pozo F; Pérez-Olmeda M; Thomson MM; Alcamí J; Casas I
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33127745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and genetic characterization of SARS-CoV-2 from Indian patients in a single family without H/O travel abroad.
    Shrivastava S; Patil HP; Mhaske ST; Palkar S; Lalwani S; Mishra AC; Arankalle VA
    Virus Genes; 2021 Jun; 57(3):245-249. PubMed ID: 33683658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haplotype distribution of SARS-CoV-2 variants in low and high vaccination rate countries during ongoing global COVID-19 pandemic in early 2021.
    Bui NN; Lin YT; Huang SH; Lin CW
    Infect Genet Evol; 2022 Jan; 97():105164. PubMed ID: 34848355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.